TriSalus Life Sciences

TriSalus Life Sciences

Yahoo Finance • 6 days ago

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, June 17, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TriSalus Life Sciences, Inc. (“TriSalus” or “the Compa... Full story

Yahoo Finance • 14 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TriSalus Life Sciences Inc. (“TriSalus” or the “Company”) (NASDAQ: TLSI).  Such investors are advised to contact Danielle Peyton... Full story

Yahoo Finance • last month

Nasdaq Surges Over 1%; Alibaba Shares Gain After Q4 Results

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 1% on Wednesday. The Dow traded down 0.24% to 49,638.96 while the NASDAQ gained 1.18% to 26,395.66. The S&P 500 also rose, gaining, 0.60% to 7,445.55.... Full story

Yahoo Finance • last month

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Quantum Cyber (NASDAQ:QUCY) shares rose 163.0% to $0.85 during Wednesday's regular session. The market value of their outstanding shares is at $4.0 million. Whitehawk Therapeutics (NASDAQ:WHWK) stock moved upwards by 29.59% to $5.... Full story

Yahoo Finance • last month

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26%... Full story

Yahoo Finance • 4 months ago

TriSalus Life Sciences reaffirms $60M–$62M revenue guidance for 2026 while expanding PEDD portfolio

Earnings Call Insights: TriSalus Life Sciences (TLSI) Q4 2025 MANAGEMENT VIEW * CEO Mary Szela reported that "our results for both the fourth quarter and the full year were strong. Fourth quarter revenues were $13.2 million, and full y... Full story

Yahoo Finance • 7 months ago

TriSalus reaffirms 50% revenue growth target while advancing TriNav platform and product launches

Earnings Call Insights: TriSalus Life Sciences (TLSI) Q3 2025 MANAGEMENT VIEW * CEO Mary Szela reported strong third quarter results, highlighting revenue of $11.6 million, a 57% increase year-over-year and 3% sequential growth. She no... Full story

Yahoo Finance • 10 months ago

TriSalus outlines 50% revenue growth target for 2025 while advancing TriNav platform and streamlining costs

Earnings Call Insights: TriSalus Life Sciences (TLSI) Q2 2025 MANAGEMENT VIEW * CEO Mary T. Szela stated the company delivered $11.2 million in net sales for Q2 2025, marking a 52% year-over-year jump and a 22% sequential increase. She... Full story

Yahoo Finance • 10 months ago

TriSalus study shows promising results for thyroid disease treatment

WESTMINSTER, Colo. - TriSalus Life Sciences Inc. (NASDAQ:TLSI), a $149.46 million market cap medical technology company, announced clinical data showing its Pressure-Enabled Drug Delivery technology demonstrated effectiveness in treating s... Full story

Yahoo Finance • last year

TriSalus shareholders elect directors, ratify auditor

WESTMINSTER, CO - TriSalus Life Sciences, Inc. (Nasdaq:TLSI), a medical device and pharmaceutical company with a market capitalization of $204 million and significant revenue growth of 46% over the last twelve months, announced the results... Full story